1. Edap Tms SA s buy rating reiterated at HC Wainright. $4.50 PT. http://www.analystratings.net/stocks/NASDAQ/EDAP/?RegistrationCode=SocialMedia-direct $EDAP

  2. $NYMX This company $EDAP has the cure for prostata cancer, and has filed a direct de novo to the fda. Look into the company. ;)

  3. @SmarterAnalyst: H.C. Wainwright Analysts Weigh in on 4 Healthcare Stocks http://www.smarteranalyst.com/2015/05/15/h-c-wainwright-weighs-in-on-4-healthcare-stocks-dara-biosciences-inc-spectrum-pharmaceuticals-inc-celladon-corp-edap-tms-sa-adr/ $DARA $SPPI $CLDN $EDAP

  4. H.C. Wainwright Analysts Weigh in on 4 Healthcare Stocks http://www.smarteranalyst.com/2015/05/15/h-c-wainwright-weighs-in-on-4-healthcare-stocks-dara-biosciences-inc-spectrum-pharmaceuticals-inc-celladon-corp-edap-tms-sa-adr/ $DARA $SPPI $CLDN $EDAP

  5. Reading remarks offered up in the $EDAP transcript http://www.conferencecalltranscripts.org/include/?location=http://seekingalpha.com/article/3179126-edap-tms-edap-ceo-marc-oczachowski-on-q1-2015-results-earnings-call-transcript

  6. Edap Tms SA announces earnings. ($0.11) EPS. Misses estimates. $EDAP http://www.analystratings.net/stocks/NASDAQ/EDAP/?RegistrationCode=SocialMedia-direct&DefaultTab=Earnings

  7. $EDAP Edap Tms SA (ADR) Reports First Quarter 2015 Results http://www.smarteranalyst.com/2015/05/12/stock-update-nasdaqedap-edap-tms-sa-adr-reports-first-quarter-2015-results/

  8. EDAP TMS: Edap Reports First Quarter 2015 Results EXHIBIT 99.1 http://www.conferencecalltranscripts.org/8/summary2/?id=1690139 $EDAP

  9. Earnings announcement: $EDAP is scheduled to report quarterly earnings on Tue, May 12 2015

  10. $EDAP Fundamentals haven t changed. Best smallcap bio out there.

  11. $EDAP is there any upcoming news ? Or approval from fda ?

  12. $EDAP might be time to consider re-entry here for a short term swing trade

  13. $EDAP has hat it s dip. Up Form here

  14. $EDAP EDAP TMS SA $EDAP ~ BUY ~ 5 Day Price Target: $3.75 Issued 04/10/2015 By Stock Price Target http://stockpricetarget.blogspot.com/2015/04/edap-tms-sa-edap-buy-5-day-price-target.html

  15. $EDAP H.C. Wainwright Reiterates Buy on Edap Tms SA (ADR) Following 4Q:14 Update http://www.smarteranalyst.com/2015/04/06/h-c-wainwright-reiterates-buy-edap-tms-sa-adr-following-4q14-update/

  16. $EDAP now that the ER is behind us, it s time for the run in to the FDA approval to begin.

  17. Annual and transition report of foreign private issuers [Sections 13 or 15(d)] http://www.conferencecalltranscripts.org/no/summary2/?id=1590089 $EDAP

  18. $EDAP: New SEC Filing for EDAP: Form IRANNOTICE, No. 0001171843-15-001793 http://stocknewsflow.com/1041934_000117184315001793_0001171843-15-001793

  19. Worth checking out notes suggested in $EDAP conference transcript http://www.conferencecalltranscripts.org/include/?location=http://seekingalpha.com/article/3048046-edap-tms-edap-ceo-marc-oczachowski-on-q4-2014-results-earnings-call-transcript

  20. $EDAP 4Q14 Q&A – Jon, Low Tide: Putting comparative data on InSightec? CEO: We take note of you comment.

  21. $EDAP 4Q14 Q&A – Jon, Low Tide: Am I correct that per treatment price for focal devices is EUR700-800? CEO: Is around EUR800-900.

  22. $EDAP 4Q14 Q&A – RK, H.C: HIFU for liver cancer? CEO: That’s still in the research project, now we are moving into new and advance phases.

  23. $EDAP 4Q14 Q&A – RK, H.C: How is De Novo different from PMA? CEO: It’s all explained in the FDA’s website.

  24. $EDAP 4Q14 Q&A – RK, H.C: 510k Application new data? CEO: We don’t need to start any new clinical study to provide new data.

  25. $EDAP 4Q14 Call – Eric, CFO: FY14 total revenue $35.4MM, up 11.2% vs. $32MM in FY13 and net loss was $676,000 vs. $6.7MM in FY13.